Circulating uncarboxylated matrix Gla protein in patients with atrial fibrillation or heart failure with preserved ejection fraction

References

• Agatston, A.S., et al., 1990. Quantification of coronary artery calcium using ultrafast CT. Journal of the American college of cardiology, 15 (4), 827–832.
   PubMed Web of Science ®Google Scholar
• Albu, A., Para, I., and Porojan, M., 2020. Uric acid and arterial stiffness. Therapeutics and clinical risk management, 16, 39–54.
   PubMed Web of Science ®Google Scholar
• Aronne, L.J., 2002. Classification of obesity and assessment of obesity-related health risks. Obesity research, 10 (S12), 105S–115S.
   PubMedGoogle Scholar
• Chen, N.X., and Moe, S.M., 2015. Pathophysiology of vascular calcification. Current osteoporosis reports, 13 (6), 372–380.
   PubMed Web of Science ®Google Scholar
• Church, T.S., et al., 2007. Coronary artery calcium score, risk factors, and incident coronary heart disease events. Atherosclerosis, 190 (1), 224–231.
   PubMed Web of Science ®Google Scholar
• Cicero, A.F., et al., 2017. Brisighella Heart Study Group. High serum uric acid is associated to poorly controlled blood pressure and higher arterial stiffness in hypertensive subjects. European journal of internal medicine, 37, 38–42.
   PubMed Web of Science ®Google Scholar
• Cranenburg, E.C., et al., 2008. The circulating inactive form of matrix Gla Protein (ucMGP) as a biomarker for cardiovascular calcification. Journal of vascular research, 45 (5), 427–436.
   PubMed Web of Science ®Google Scholar
• Cranenburg, E.C., et al., 2010. Characterisation and potential diagnostic value of circulating matrix Gla protein (MGP) species. Thrombosis and haemostasis, 104 (4), 811–822.
   PubMed Web of Science ®Google Scholar
• Cranenburg, E.M., et al., 2009. Uncarboxylated matrix Gla protein (ucMGP) is associated with coronary artery calcification in haemodialysis patients. Thrombosis and haemostasis, 101 (02), 359–366.
   PubMedGoogle Scholar
• Dalmeijer, G.W., et al., 2013. Circulating species of matrix Gla protein and the risk of vascular calcification in healthy women. International journal of cardiology, 168 (6), e168–e170. Available from: https://www.sciencedirect.com/science/article/pii/S0167527313016240?via%3Dihub [Accessed 15 October 2013].
   PubMed Web of Science ®Google Scholar
• Demer, L.L., and Tintut, Y., 2008. Vascular calcification: pathobiology of a multifaceted disease. Circulation, 117 (22), 2938–2948.
   PubMed Web of Science ®Google Scholar
• El Asmar, M.S., Naoum, J.J., and Arbid, E.A., 2014. Vitamin K dependent proteins and the role of vitamin K2 in the modulation of vascular calcification: a review. Oman medical journal, 29 (3), 172–177.
   PubMedGoogle Scholar
• Hecht, H.S., 2015. Coronary artery calcium scanning: past, present, and future. Jacc cardiovascular imaging, 8 (5), 579–596.
   PubMed Web of Science ®Google Scholar
• Hermans, M.M., et al., 2007. Undercarboxylated matrix Gla protein levels are decreased in dialysis patients and related to parameters of calcium-phosphate metabolism and aortic augmentation index. Blood purification, 25 (5–6), 395–401.
   PubMed Web of Science ®Google Scholar
• Jespersen, T., et al., 2020. Uncarboxylated Matrix Gla-Protein: A Biomarker of Vitamin K Status and Cardiovascular Risk. Clinical biochemistry, S0009-9120(20)30031-X. Available from: https://www.sciencedirect.com/science/article/pii/S000991202030031X?via%3Dihub [Accessed 15 May 2020].
   PubMedGoogle Scholar
• Johnson, R.C., Leopold, J.A., and Loscalzo, J., 2006. Vascular calcification: pathobiological mechanisms and clinical implications. Circulation research, 99 (10), 1044–1059.
   PubMed Web of Science ®Google Scholar
• Jono, S., et al., 2004. Matrix Gla protein is associated with coronary artery calcification as assessed by electron-beam computed tomography. Thrombosis and haemostasis, 91 (04), 790–794.
   PubMedGoogle Scholar
• Jun, J.E., et al., 2018. Elevated serum uric acid predicts the development of moderate coronary artery calcification independent of conventional cardiovascular risk factors. Atherosclerosis, 272, 233–239.
   PubMed Web of Science ®Google Scholar
• Kiss, L.Z., et al., 2019. Serum uric acid is independently associated with coronary calcification in an asymptomatic population. Journal of cardiovascular translational research, 12 (3), 204–210.
   PubMed Web of Science ®Google Scholar
• Larsen, T.R., et al., 2018. The association between uric acid levels and different clinical manifestations of coronary artery disease. Coronary artery disease, 29 (3), 194–203.
   PubMed Web of Science ®Google Scholar
• Li, C., et al., 2020. Matrix Gla protein regulates adipogenesis and is serum marker of visceral adiposity. Adipocyte, 9 (1), 68–76.
   PubMed Web of Science ®Google Scholar
• Liabeuf, S., et al., 2014. Vascular calcification in patients with type 2 diabetes: the involvement of matrix Gla protein. Cardiovascular diabetology, 13, 85. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017083/pdf/1475-2840-13-85.pdf [Accessed 24 April 2014].
   PubMed Web of Science ®Google Scholar
• Liang, L., et al., 2019. The association between hyperuricemia and coronary artery calcification development: a systematic review and meta-analysis. Clinical cardiology, 42 (11), 1079–1086.
   PubMed Web of Science ®Google Scholar
• London, G.M., 2000. Cardiovascular risk in end-stage renal disease: vascular aspects. Nephrology dialysis transplantation, 15 (90005), 97–104.
   PubMedGoogle Scholar
• Luo, G., et al., 1997. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature, 386 (6620), 78–81.,
   PubMed Web of Science ®Google Scholar
• Mach, F., et al., 2020. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: the task force for the management of dyslipidaemias of the European society of cardiology (ESC) and European atherosclerosis society (EAS). European heart journal, 41 (1), 111–188.
   PubMed Web of Science ®Google Scholar
• Mayank, S., et al., 2017. Inactive matrix Gla-protein and arterial stiffness in type 2 diabetes mellitus. American journal of hypertension, 30 (2), 196–201 .
   PubMed Web of Science ®Google Scholar
• Muiesan, M.L., et al., 2016. Uric acid and cardiovascular disease: an update. European cardiology, 11 (1), 54–59.
   PubMed Web of Science ®Google Scholar
• Nelson, A.J., et al., 2020. Targeting vascular calcification in chronic kidney disease. JAAC basic to translational science, 5 (4), 398–412.
   Google Scholar
• New, S.E., and Aikawa, E., 2013. Role of extracellular vesicles in de novo mineralization: an additional novel mechanism of cardiovascular calcification. Arteriosclerosis thrombosis and vascular biology, 33 (8), 1753–1758.
   PubMed Web of Science ®Google Scholar
• Nigwekar, S.U., et al., 2017. Vitamin K-dependent carboxylation of matrix Gla protein influences the risk of calciphylaxis. Journal of the American society of nephrology, 28 (6), 1717–1722.
   PubMed Web of Science ®Google Scholar
• O'Young, J., et al., 2011. Matrix Gla protein inhibits ectopic calcification by a direct interaction with hydroxyapatite crystals. Journal of the American chemical society, 133 (45), 18406–18412.
   PubMed Web of Science ®Google Scholar
• Pesaro, A.E., et al., 2018. Circulating osteogenic proteins are associated with coronary artery calcification and increase after myocardial infarction. Plos one, 13 (8), e0202738. Available from: 10.1371/journal.pone.0202738 [Accessed 23 August 2018].
   PubMed Web of Science ®Google Scholar
• Piepoli, M.F., et al., 2016. European Guidelines on cardiovascular disease prevention in clinical practice: The sixth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European association for cardiovascular prevention & Rehabilitation (EACPR). European heart journal, 37 (29), 2315–2381.
   PubMed Web of Science ®Google Scholar
• Pletcher, M.J., et al., 2004. Using the coronary artery calcium score to predict coronary heart disease events: a systematic review and meta-analysis. Archives of internal medicine, 164 (12), 1285–1292.
   PubMedGoogle Scholar
• Price, P.A., et al., 2006. The elastic lamellae of devitalized arteries calcify when incubated in serum: evidence for a serum calcification factor. Arteriosclerosis, thrombosis, and vascular biology, 26 (5), 1079–1085.
   PubMed Web of Science ®Google Scholar
• Rennenberg, R.J., et al., 2009. Vascular calcifications as a marker of increased cardiovascular risk: a meta-analysis. Vascular health and risk management, 5 (1), 185–197.
   PubMedGoogle Scholar
• Rennenberg, R.J., et al., 2010. Calcium scores and matrix Gla protein levels: association with vitamin K status. European journal of clinical investigation, 40 (4), 344–349.
   PubMed Web of Science ®Google Scholar
• Reynolds, J.L., et al., 2005. Multifunctional roles for serum protein fetuin-a in inhibition of human vascular smooth muscle cell calcification. Journal of the American society of nephrology, 16 (10), 2920–2930.
   PubMed Web of Science ®Google Scholar
• Roijers, R.B., et al., 2011. Microcalcifications in early intimal lesions of atherosclerotic human coronary arteries. The American journal of pathology, 178 (6), 2879–2887.
   PubMed Web of Science ®Google Scholar
• Roumeliotis, S., et al., 2019. Association of the inactive circulating matrix Gla protein with vitamin K intake, calcification, mortality, and cardiovascular disease: a review. International journal of molecular sciences, 20 (3). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387246/ [Accessed 1 February 2019].
   Web of Science ®Google Scholar
• Roumeliotis, S., et al., 2020. Vascular calcification in chronic kidney disease: the role of vitamin K- dependent matrix Gla protein. Frontiers in medicine, 7 (154). Available from: 10.3389/fmed.2020.00154 [Accessed 24 April 2020].
   Google Scholar
• Sage, A.P., et al., 2011. Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro. Kidney international, 79 (4), 414–422.
   PubMed Web of Science ®Google Scholar
• Schurgers, L.J., 2013. Vitamin K: key vitamin in controlling vascular calcification in chronic kidney disease. Kidney international, 83 (5), 782–784.
   PubMed Web of Science ®Google Scholar
• Schurgers, L.J., et al., 2001. Role of vitamin K and vitamin K-dependent proteins in vascular calcification. Zeitschrift für Kardiologie, 90, 57–63.
   Google Scholar
• Schurgers, L.J., et al., 2005. Novel conformation-specific antibodies against matrix gamma-carboxyglutamic acid (Gla) protein: undercarboxylated matrix Gla protein as marker for vascular calcification. Arteriosclerosis, thrombosis, and vascular biology, 25 (8), 1629–1633.
   PubMed Web of Science ®Google Scholar
• Schurgers, L.J., et al., 2010. The circulating inactive form of matrix Gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report. Clinical journal of the American society of nephrology, 5 (4), 568–575.
   PubMed Web of Science ®Google Scholar
• Shanahan, C.M., 2005. Mechanisms of vascular calcification in renal disease. Clinical nephrology, 63 (2), 146–157.
   PubMed Web of Science ®Google Scholar
• Shea, M.K., et al., 2011. Circulating uncarboxylated matrix Gla protein is associated with vitamin K nutritional status, but not coronary artery calcium, in older adults. The journal of nutrition, 141 (8), 1529–1534.
   PubMed Web of Science ®Google Scholar
• Silaghi, C.N., Fodor, D., and Crăciun, A.M., 2013. Circulating matrix Gla protein: a potential tool to identify minor carotid stenosis with calcification in a risk population. Clinical chemistry and laboratory medicine, 51 (5), 1115–1123.
   PubMed Web of Science ®Google Scholar
• Sokoll, L.J., and Sadowski, J.A., 1996. Comparison of biochemical indexes for assessing vitamin K nutritional status in a healthy adult population. The American journal of clinical nutrition, 63 (4), 566–573.
   PubMed Web of Science ®Google Scholar
• Spronk, H.M., et al., 2001. Matrix Gla protein accumulates at the border of regions of calcification and normal tissue in the media of the arterial vessel wall. Biochemical and biophysical research communications, 289 (2), 485–490.
   PubMed Web of Science ®Google Scholar
• Szulc, P., 2016. Abdominal aortic calcification: a reappraisal of epidemiological and pathophysiological data. Bone, 84, 25–37.
   PubMed Web of Science ®Google Scholar
• Thomsen, S.B., et al., 2010. Increased levels of the calcification marker matrix Gla Protein and the inflammatory markers YKL-40 and CRP in patients with type 2 diabetes and ischemic heart disease. Cardiovascular diabetology, 9 (1), 86. Available from: 10.1186/1475-2840-9-86 [Accessed 08 December 2010].
   PubMedGoogle Scholar
• Ueland, T., et al., 2010. Undercarboxylated matrix Gla protein is associated with indices of heart failure and mortality in symptomatic aortic stenosis. Journal of internal medicine, 268 (5), 483–492.
   PubMed Web of Science ®Google Scholar
• Wyskida, K., et al., 2016. Functional deficiency of vitamin K in hemodialysis patients in Upper Silesia in Poland. International urology and nephrology, 48 (5), 765–771.
   PubMed Web of Science ®Google Scholar
• Zhu, D., et al., 2012. Mechanisms and clinical consequences of vascular calcification. Frontiers in endocrinol (lausanne), 3, 95. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412412/pdf/fendo-03-00095.pdf [Accessed 06 August 2012].
   PubMedGoogle Scholar